![logo](/logos/H02.SI.webp)
Haw Par Corporation Limited
SGX:H02.SI
10.45 (SGD) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Haw Par Corporation Limited |
Symbool | H02.SI |
Munteenheid | SGD |
Prijs | 10.45 |
Beurswaarde | 2,313,295,600 |
Dividendpercentage | 4.12% |
52-weken bereik | 9.44 - 10.57 |
Industrie | Drug Manufacturers—General |
Sector | Healthcare |
CEO | Mr. Ee Lim Wee |
Website | https://www.hawpar.com |
An error occurred while fetching data.
Over Haw Par Corporation Limited
Haw Par Corporation Limited, together with its subsidiaries, manufactures, markets, and trades in healthcare products in Singapore, ASEAN countries, other Asian countries, and internationally. The company operates through three segments: Healthcare, Investments, and Others. The Healthcare segment principally manufactures and distributes topical analgesic products under the Tiger Balm and Kwan
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (SGD)
Cijfers zijn in miljoenen (SGD)